China Cord Blood Corp. (NYSE:CO) shares fell 1.7% during mid-day trading on Thursday . The company traded as low as $5.01 and last traded at $5.15, with a volume of 81,132 shares changing hands. The stock had previously closed at $5.24.

A number of research firms recently issued reports on CO. Zacks Investment Research lowered shares of China Cord Blood Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, July 19th. TheStreet downgraded shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $7.00.

The firm’s 50 day moving average price is $5.47 and its 200 day moving average price is $5.89. The company has a market capitalization of $408.42 million and a PE ratio of 27.27.

China Cord Blood Corp. (NYSE:CO) last announced its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.03. The business earned $24.30 million during the quarter. On average, analysts predict that China Cord Blood Corp. will post $0.17 earnings per share for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.